Skip to Main Content
Skip Nav Destination
Issue Cover
Current Issue
Volume 2023,
Issue 1,
December 8 2023

The Hematology ASH Education Program 2023 provides review articles from the Education Program at the 2023 ASH Annual Meeting. In this publication, each chapter relates to a different session presented at the meeting, spanning the spectrum from basic discovery and disease pathogenesis to the clinical application at the bedside.

This activity is supported by educational grants from AstraZeneca; GlaxoSmithKline; Incyte Corp.; Jazz Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.; and Novartis Pharmaceuticals Corp.

Cover: Illustration of activated platelets. | Source: Kateryna Kon/Science Photo Library.

Featured Content

Medical consult: aHUS, TTP? How to distinguish and what to do

Learning Objectives

  • Identify patterns of clinical features and use clinical decision tools to distinguish iTTP from aHUS
  • Understand the interpretation and application of ADAMTS13 assays for iTTP diagnosis

Current use of CAR T cells to treat multiple myeloma

Learning Objectives

  • Discuss practical considerations for CAR T-cell products currently approved by the US Food and Drug Administration and potential expanded indications for those agents
  • Explore currently available research regarding challenges with therap
  • Evaluate treatment options following relapse from CAR T-cell therapy

Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL

Learning Objectives

  • Review the current landscape of subacute/delayed toxicities following CAR T-cell therapy
  • Identify approaches to evaluation and management of delayed toxicities following CAR T cells
  • Recognize the need for study of late effects in long-term survivors following CAR T-cell therapy
Close Modal

or Create an Account

Close Modal
Close Modal